SCHEMBL8516060

SCHEMBL8516060

CC(C)[Si](O)(c1cccc(N(c2ccccc2)c2ccc(-c3ccc(N(c4ccccc4)c4cccc([Si](O)(C(C)C)C(C)C)c4)cc3)cc2)c1)C(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
ALDH1A1 P00352 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
APP P05067 1/20 0.33
ALOX5 P09917 1/20 0.32
GAA P10253 1/20 0.32
PKM P14618 1/20 0.32
PTGS2 P35354 2/20 0.31
BCL2L1 Q07817 1/20 0.31
MCL1 Q07820 1/20 0.31
MEN1 O00255 1/20 0.31
CRHBP P24387 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8514131 0.94 ALDH1A1 (0.35) CYP1A2CYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL9918119 0.88 SLC6A2 (0.36) CYP1A2CYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL9918120 0.83 ALDH1A1 (0.36) CYP1A2CYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL17118568 0.77 ALDH1A1 (0.39) CYP1A2CYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL2329501 0.76 ALDH1A1 (0.40) CYP1A2CYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL2018454 0.75 RELA (0.43) CYP1A2CYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL9918118 0.75 NR1H2 (0.42) CYP1A2CYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL9918117 0.74 ALDH1A1 (0.39) CYP1A2CYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL17118577 0.74 ALDH1A1 (0.39) CYP1A2CYP2C9CYP2C19ALDH1A1L3MBTL1
SCHEMBL21365243 0.73 L3MBTL1 (0.37) CYP1A2CYP2C9CYP2C19ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2457917-B1 Silanol-containing triarylamine derivatives SHINETSU CHEMICAL CO (JP) 2014-06-18 EP disclosed
US-8575384-B2 Silanol-containing triarylamine derivatives SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-11-05 US disclosed
US-20120149913-A1 SILANOL-CONTAINING TRIARYLAMINE DERIVATIVES SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-06-14 US disclosed
EP-2457917-A1 Silanol-containing triarylamine derivatives Shin-Etsu Chemical Co., Ltd. (JP) 2012-05-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149913-A1 SILANOL-CONTAINING TRIARYLAMINE DERIVATIVES SIK2, AS3MT, ILK CYP1A2 306/4885CYP2C9 694/4885CYP2C19 1042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.